146 related articles for article (PubMed ID: 25813864)
1. Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer.
Liang YX; Mo RJ; He HC; Chen JH; Zou J; Han ZD; Lu JM; Cai C; Zeng YR; Zhong WD; Wu CL
Oncol Rep; 2015 May; 33(5):2648-54. PubMed ID: 25813864
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma.
Kong LM; Liao CG; Chen L; Yang HS; Zhang SH; Zhang Z; Bian HJ; Xing JL; Chen ZN
J Cell Mol Med; 2011 Jun; 15(6):1415-28. PubMed ID: 20629990
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
4. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
6. CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features.
Bauman TM; Ewald JA; Huang W; Ricke WA
BMC Cancer; 2015 Jul; 15():549. PubMed ID: 26209327
[TBL] [Abstract][Full Text] [Related]
7. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference.
Wang L; Wu G; Yu L; Yuan J; Fang F; Zhai Z; Wang F; Wang H
Cancer Biol Ther; 2006 Jun; 5(6):608-14. PubMed ID: 16627983
[TBL] [Abstract][Full Text] [Related]
9. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.
Kwabi-Addo B; Ren C; Ittmann M
Epigenetics; 2009 Jan; 4(1):54-61. PubMed ID: 19164898
[TBL] [Abstract][Full Text] [Related]
11. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypomethylation and upregulation of trefoil factors in prostate cancer.
Vestergaard EM; Nexø E; Tørring N; Borre M; Ørntoft TF; Sørensen KD
Int J Cancer; 2010 Oct; 127(8):1857-65. PubMed ID: 20112343
[TBL] [Abstract][Full Text] [Related]
16. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
Zhang J; Li Q; Zhang S; Xu Q; Wang T
Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
[TBL] [Abstract][Full Text] [Related]
17. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation.
Zeng W; Su J; Wu L; Yang D; Long T; Li D; Kuang Y; Li J; Qi M; Zhang J; Chen X
Curr Mol Med; 2014 Jan; 14(1):163-73. PubMed ID: 24090196
[TBL] [Abstract][Full Text] [Related]
18. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis.
Dou M; Zhou X; Fan Z; Ding X; Li L; Wang S; Xue W; Wang H; Suo Z; Deng X
Cell Physiol Biochem; 2018; 45(6):2497-2505. PubMed ID: 29554659
[TBL] [Abstract][Full Text] [Related]
20. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
